INSIGHTS ON DRUG DEVELOPMENT
-
Accelerate To Win: The Challenges Of Dosage Form Development
Clinical momentum starts before the clinic. Formulation, manufacturing, and dosage form strategies can shape a program's future trajectory.
-
Viral Gene Therapy: Reducing Costs To Improve Patient Access
Gene therapy is revolutionizing medicine with its potential to cure genetic disorders. As approvals rise, so do concerns about accessibility, with million-dollar price tags limiting patient access.
-
Strategies For The Development Of Safe And Effective Pediatric Formulations
Medicines for infants and children face unique formulation challenges. Learn about the key considerations, including developmental physiology, age specifics, palatability, ease of administration, and precise dosing.
-
Overview Of Hot Melt Extrusion And Its Pharmaceutical Applications
More than 40% of NCEs face aqueous solubility challenges. Here, we examine how hot melt extrusion addresses solubility, modified release, abuse deterrence, and scale-up across pharmaceutical development.
-
Enhanced Validation Data Anti-EGFRvIII Recombinant Antibody3/24/2025
Select the right antibody clone by exploring enhanced validation data for top recombinant antibody clones that offer comprehensive specificity and sensitivity insights tailored to your project's unique requirements.
-
Inside Bioprocessing: Microbial Media11/4/2025
Learn the reasons why the animal origin-free trend in bioprocessing has taken so long to reach microbial bioproduction and the technical hurdles overcome during the development of Gibco CD Bacto Supreme.
-
Advancing Cell Culture Strategies To Accelerate Biologics Development5/5/2026
Integrated stable expression strategies accelerate biologics material generation, improving scalability, consistency, and early developability insights while reducing bottlenecks, variability, and risks in transitioning from discovery to manufacturing.
-
Characterizing Quality Attributes Of GLP-1 Analogs By Light Scattering7/31/2025
Explore how light scattering reveals the structural integrity, aggregation, and stability of GLP-1 analogs to advance drug formulation and enhance treatment efficacy for type 2 diabetes and obesity.
-
Navigating Nitrosamine Impurities In Pharmaceutical Drug Development3/3/2026
Understanding formation mechanisms and potency categorization allows developers to mitigate risks early, ensuring regulatory compliance and patient safety without compromising product performance.
DRUG DEVELOPMENT SOLUTIONS
-
Navigating the complexities of oral solid dose (OSD) drug development requires a careful balance of phase-appropriate formulation, process optimization, and scalable commercial manufacturing.
-
Our expertise and capabilities enable us to meet the complex technical challenges of pediatric products and provide you with a unique integrated development solution.
-
Optimize Your GC Analysis with Zebron GC Columns
Zebron GC columns are engineered with quality of analysis in mind to better support scientists' research and regulatory analysis for environmental, food safety, food quality, forensics, pharma, fuels, and specialty chemicals.
-
Gain human-relevant insights with patient-derived assay-ready organoids.
-
Explore a suite of services designed to accelerate drug discovery and development, from custom reagent production and high-throughput screening to advanced in vitro pharmacology and DMPK assays.